| Hematological studies: |
|---|
| Reticulocyte count |
| Erythrocyte count with basophilic granularity |
| Platelet count |
| Determination of erythrocyte sedimentation rate (ESR) |
| Complete blood count using automatic analyzers with differentiation of the leukocyte formula |
| Manual calculation of the leukocyte formula with a description of the morphology of blood cells |
| Immunohematological studies: |
| Determination of the blood group according to the ABO system and the Rh factor using the gel technology method (DiaMed ID-cards) |
| Screening of anti-erythrocyte antibodies (indirect Coombs test) using gel technology (DiaMed ID-cards) |
| Direct Coombs test using gel technology (DiaMed ID-cards) |
| Determination of the blood group according to the ABO system and the Rh factor using the gel technology method (DiaMed ID-cards) for newborns / children of the first year of life |
| ID-Antigenprofile I |
| ID-Antigenprofile II |
| ID-Antigenprofile III |
| DiaClon Rh-subgroups + K phenotyping of Rhesus and Kell system erythrocytes, detection of C-c-E-e-K-ctl antigens |
| Testing of the hemostasis system |
| The study of platelet aggregation during stimulation |
| ASPI test (with hirudin) |
| ADP test (with hirudin) |
| ADP-HS test (with hirudin) |
| TRAP test (with hirudin) |
| Coagulogram |
| APTT (activated partial thromboplastin time) |
| Fibrinogen |
| Determination of thrombin time with a standard amount of thrombin |
| Prothrombin time expressed as INR |
| Clotting factors |
| Determination of factor II in blood plasma using factor II deficient plasma |
| Plasma Factor V Determination Using Factor V-Deficient Plasma |
| Determination of factor V Leiden APC resistance |
| Determination of factor VII in blood plasma using plasma deficient in factor VII |
| Determination of factor VIII in blood plasma using plasma deficient in factor VIII |
| Determination of factor VIII inhibitor |
| Determination of factor IX in plasma using factor IX-deficient plasma |
| Determination of factor IX inhibitor |
| Determination of factor X in plasma using factor X-deficient plasma |
| Determination of factor XI in plasma using factor XI deficient plasma |
| Determination of factor XII in blood plasma using factor XII deficient plasma |
| Determination of von Willebrand factor antigen |
| Determination of von Willebrand factor activity |
| Control of anticoagulant therapy |
| UHF non-fractional heparin concentration |
| Low molecular weight heparin concentration LMWH |
| Rivaroxaban concentration |
| Anticoagulant and fibrinolytic system |
| D-DIMER highly sensitive |
| Determination of antithrombin III with a chromogenic substrate on an automatic coagulometer |
| Determination of plasminogen with a chromogenic substrate on an automatic coagulometer |
| Determination of antiplasmin with a chromogenic substrate on an automatic coagulometer |
| Determination of protein C with a chromogenic substrate on an automatic coagulometer |
| Determination of protein S with a chromogenic substrate on an automatic coagulometer |
| Lupus anticoagulant (complex) |
| APTT (activated partial thromboplastin time) |
| APTT Silica STC Screen screening test |
| APTT Silica STC Confirm confirmation test |
| dRVVT APTT using diluted Russell's viper venom screening test |
| APTT dRVVT using diluted Russell's viper venom confirmatory test |
| Biochemical blood assay |
| Protein metabolism |
| Total protein |
| Albumen |
| Prealbumin |
| Uric acid |
| Urea |
| Creatinine |
| Liver parameters |
| Total bilirubin |
| Birect bilirubin |
| AST (Aspartate aminotransferase) |
| ALT (Alanine aminotransferase) |
| Alkaline phosphatase |
| GGT (Gamma-glutamyltransferase) |
| Cholinesterase |
| Renal indicators |
| Albumen |
| Urea |
| Creatinine |
| Creatinine enzymatic |
| Cystatin C |
| Magnesium |
| Phosphorus |
| Potassium |
| Sodium |
| Chlorine |
| Indicators of lipid metabolism |
| total cholesterol |
| Triglycerides |
| HDL cholesterol |
| LDL cholesterol |
| Atherogenic index / atherogenic coefficient (CA) |
| Apolyprotein A1 |
| Apoliprotein B |
| Lipoprotein Lp(a) |
| Indicators of mineral metabolism |
| Calcium total |
| Magnesium |
| Phosphorus |
| Potassium |
| Sodium |
| Chlorine |
| Accumulation of iron |
| Serum iron |
| Transferrin |
| ferritin |
| TIBC (Iron Metabolism) |
| Haptoglobin |
| Pancreatic enzymes |
| Amylase |
| P-amylase (pancreatic) |
| Lipase |
| Proteins of acute phase of inflammation |
| Immunoglobulins lg A |
| Immunoglobulins lg M |
| Immunoglobulins lg G |
| Immunoglobulin IgE |
| Complement C4 |
| Complement SZ |
| Antitrypsin a1 |
| Kappa chains of immunoglobulins |
| Lambda chains of immunoglobulins |
| Rheumatoid factor |
| Antistreptolysin O (ASO) A-SO |
| C-reactive protein |
| ceruloplasmin |
| Beta-2 microglobulin |
| Markers of cardiovascular disease |
| CK (creatine kinase) |
| CK-MB (creatine kinase enzyme isoform) |
| LDH (lactate dehydrogenase) |
| HBDH HBDG (hydroxybutyrate dehydrogenase) |
| Myoglobin |
| Indicators of carbohydrate metabolism |
| Glucose |
| Glycated hemoglobin |
| Urinalysis: |
| General urinalysis (study of a set of parameters of a general urinalysis using semi-automatic analyzers based on dry chemistry methods) |
| Microscopic examination of the sediment in the urine |
| Determination of protein in urine (in case of pathology) |
| Urinalysis according to Nechiporenko (counting the number of formed elements by the Nechiporenko method) |
| Urinalysis according to Zimnitsky (determination of the concentration ability of the kidneys according to Zimnitsky) |
| Microalibuminuria MAU (biochemical analysis of urine) |
| Hematological examinations performed in the clinical diagnostic laboratory of the bone marrow transplantation service. The research using hematological analyzers: |
| Automatic, with differentiation of the leukocyte formula |
| Reticulocyte count |
| Determination of the erythrocyte sedimentation rate |
| Calculation of the leukocyte formula with a description of the morphology of blood cells: complete blood count for hematological diseases |
| Myelogram count |
| Determination of osmotic resistance of erythrocytes |
| Examination of cerebrospinal fluid (cytosis and microscopy) |
| Immunophenotypic studies |
| Determination of the immune status |
| Determination of cytokines (for immune status) |
| Determination of the number of stem CD-34+ cells in umbilical cord blood |
| Determination of platelet-associated antibodies |
| Determination of the phenotype in PNH |
| Immunophenotyping of peripheral blood cells or bone marrow (for chronic lymphoid leukemia) |
| Immunophenotyping of bone marrow cells (for multiple myeloma) |
| Immunophenotyping of peripheral blood or bone marrow cells (for minimal residual disease) |
| Immunophenotyping of peripheral blood cells or bone marrow (for acute leukemia) |
| Cytogenetic and FISH studies |
| Cytogenetic study of the bone marrow of patients with oncohematological profile (Karyotyping) in acute leukemia |
| Cytogenetic study of the bone marrow of patients with ongohematological profile (karyotyping) chronic myelo and lymphoproliferative diseases |
| D7S522/CEP7 - determination of deletion (7q31) and number of chromosome 7 |
| CEP 12 - detection of chromosome 12 in interphase nuclei |
| ATM--ATM(11q22.3) gene deletion detection |
| BCR/ABL - determination of translocation of 9 and 22 chromosomes t (9;22) |
| CBFB definition of chromosome 16 inversion (16q22) |
| CEP 6 - quantification of chromosome 6 in interphase nuclei |
| CEP 8 - quantification of chromosome 8 in interphase nuclei |
| CEP X/Y - allograft survival control |
| CSF1R/D5S23,D5S721-determination of deletion (5q31) and chromosome number5 |
| D13S319 / 13q34 - determination of the deletion of the long arm of the 13th chromosome 13q34) and the number of 13 chromosomes |
| D20S108-Determination of a deletion of the long arm of the 20th chromosome 20q12) |
| ETV6 rearrangement of the ETV6 gene (12р13) |
| IGH/CCND1-determination of translocation of chromosomes 11 and 14 t (11;14) |
| IGH / FGFR3-determination of translocation 4 and 14 chromosomes t (4; 14) |
| IGH/MAF determination of translocation of chromosomes 14 and 16 t (14;16) |
| IGH-determination of the IGH(14q32) gene rearrangement |
| MLL definition of MLL(11q23) gene rearrangement |
| MSL1/1p12-determination of locus change 1p12 |
| MYK definition of MYK(8q24) gene rearrangement |
| N-MYC determination of N-MYC(2p23-24) gene rearrangement |
| PDGFRB-determination of PDGFRB(5q33) gene rearrangement |
| PML/RARA - determination of translocation of 15 and 17 chromosomes t (15;17) |
| RARA - definition of 17q21 locus change |
| RB-determination of the deletion of the long arm of the 13th chromosome (13q14) |
| RUNX1 / RANX1T1 ( ETO / AML1) determination of translocation 8 and 21 of chromosome t (8; 21) |
| TR53/SEP 17 - determination of deletion (17q13.1) and number of chromosome 17 |
| Protein electrophoresis by immunofixation |
| Determination of paraproteins (M-gradient) in blood serum by gel electrophoresis and protein immunofixation |
| Determination of paraproteins in urine by gel electrophoresis and protein immunofixation (protein electrophoresis by immunofixation) |
If you have any questions or want to book an appointment with a medical specialist, please call:
+375 29 33-11-969
+375 29 699-11-03
+375 17 371-00-22
+375 17 371-00-26
Contact us on email: platnoyslygi@mail.ru